格隆汇11月17日丨中伟股份(300919.SZ)公布，公司本次全球发售H股基础发行股数为104,225,400股（行 使超额配售权之前），其中，香港公开发售10,422,600股，约占全球发售总数的10.00%（行使超额配售 权之前）；国际发售93,802,800股，约占全球发售总数的90.00%（行使超额配售权之前）。根据每股H 股发售价34.00港元计算，经扣除全球发售相关承销佣金及其他估计费用后，并假设超额配售权未获行 使，公司将收取的全球发售所得款项净额估计约为34.3261亿港元。经香港联交所批准，公司本次发行 的104,225,400股H股股票（行使超额配售权之前）于2025年11月17日在香港联交所主板挂牌并上市交 易。公司H股股票中文简称为"中偉新材"，英文简称为"CNGR"，股份代号为"02579"。 ...

Market Overview - The Hong Kong stock market experienced a decline, with the Hang Seng Index falling by 0.71% to close at 26,384.28 points, and the Hang Seng Technology Index dropping by 0.96% to 5,756.88 points [2][3] - The total market turnover was HKD 217.6 billion, a decrease from HKD 232.8 billion in the previous trading day, with net inflows from southbound funds amounting to HKD 8.4 billion [3] Sector Performance - Weak performance was noted in sectors such as electrical equipment, pharmaceuticals, non-ferrous metals, chemicals, and banking, while software services, consumer goods, coal, and real estate sectors showed strength [3] Individual Stock Movements - Lenovo Group saw a decline of 3.9%, China Hongqiao fell by 3.64%, and Trip.com Group dropped by 3.56%. Conversely, Tingyi Holding rose by 2.08%, WH Group increased by 1.15%, and JD Health gained 0.95% [4] New Listings - Zhongwei New Materials debuted on the Hong Kong stock market but faced a drop of 0.12%, closing at HKD 33.96 per share, down from an issue price of HKD 34 [5][16] Notable Company Developments - Pop Mart saw a slight increase of 0.46% amid market declines, and it was reported that Sony Pictures acquired film adaptation rights for Pop Mart's LABUBU, currently in early development stages [6][9] - Alibaba's stock remained flat with a trading volume of HKD 17.6 billion. The company announced the rebranding of its flagship AI application from "Tongyi" to "Qianwen" and plans to integrate various life scenarios into the app [11][13] Government Initiatives - The Hong Kong government has initiated the "Innovation and Technology Industry Guiding Fund," focusing on strategic sectors such as life sciences, AI, microelectronics, and sustainable development, with a total investment of HKD 10 billion [21][22]

【导读】港股震荡走低，再现新股破发 11月17日，港股震荡走低。恒生指数收跌0.71%，报26384.28点；恒生科技指数收跌0.96%，报5756.88点；恒生国企指数下跌0.74%，报9328.40点。 | 序号 | 代码 | 名称 | 现价 | 涨跌 | 涨跌幅 | 成交额 | 年初至今 | | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | HSI | 恒生指数 | 26384.28c | -188.18 | -0.71% | 2176亿 | 31.53% | | 2 | HSTECH | 恒生科技 | 5756.88c | -55.92 | -0.96% | 6441Z | 28.84% | | 3 | HSBIO | 恒生生物科技 | 15959.29c | -321.53 | -1.97% | 111亿 | 85.11% | | 4 | HSCEI | 恒生中国企业指数 | 9328.40c | -69.56 | -0.74% | 793亿 | 27.96% | | 5 | HSCI | 恒生综合指数 | 4052.36c | -27. ...

中伟股份（300919）(300919.SZ)公告，公司发行的1.04亿股H股股票(行使超额配售权之前)于2025年11 月17日在中国香港联交所主板挂牌并上市交易。 ...

智通财经APP讯，中伟股份(300919.SZ)公告，公司发行的1.04亿股H股股票(行使超额配售权之前)于 2025年11月17日在中国香港联交所主板挂牌并上市交易。 ...

证券代码：300919 证券简称：中伟股份 公告编号：2025-125 中伟新材料股份有限公司 关于控股股东及其一致行动人持股比例被动稀释 中伟新材料股份有限公司（以下简称"公司"或"上市公司"）因公开发行境外上市 股份 H 股（以下简称"H 股"）104,225,400 股（行使超额配售权之前），公司总股本由 938,028,458 股增加至 1,042,253,858 股，使得公司控股股东湖南中伟控股集团有限公司（以 下简称"中伟集团"）及其一致行动人邓伟明、铜仁弘新成达企业管理咨询合伙企业（有限 合伙）（以下简称"弘新成达"）合计持股比例被动变化触及 1%和 5%整数倍。具体情况 如下： 1 1．基本情况 信息披露义务人 1 湖南中伟控股集团有限公司 住所 长沙市宁乡经济技术开发区创业大道 信息披露义务人 2 邓伟明 住所 湖南省长沙市运达中央广场写字楼 B 座 11 楼 信息披露义务人 3 铜仁弘新成达企业管理咨询合伙企业（有限合伙） 住所 贵州省大龙经济开发区管委会旁（龙晟酒店） 权益变动时间 2025 年 11 月 17 日 权益变动过程 公司于 2025 年 11 月 17 日发行 H 股并在香 ...

关于境外上市股份（H 股）挂牌并上市交易的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 证券代码：300919 证券简称：中伟股份 公告编号：2025-124 中伟新材料股份有限公司 本次发行上市完成后，公司持股 5%以上的股东及其关联方、一致行动人（香港中央 结算有限公司除外）持股变动情况如下： 1 截至2025年11月16日，公司总股本为938,028,458股。 | | 本次发行上市前 | | | 本次发行上市后 | | | | --- | --- | --- | --- | --- | --- | --- | | 股东类别 | | | 假设超额配股权未获行使 | | 假设超额配售权悉数行使 | | | | 数量（股） | 比例 | 数量（股） | 比例 | 数量（股） | 比例 | | 湖南中伟 | | | | | | | | 控股集团 | 481,600,000 | 51.34% | 481,600,000 | 46.21% | 481,600,000 | 45.52% | | 有限公司 | | | | | | | | 邓伟明 | 29,57 ...

Core Viewpoint - Zhongwei Co., Ltd. is in the process of issuing H-shares and listing on the main board of the Hong Kong Stock Exchange, aiming to raise approximately HKD 34.3261 billion from the global offering [1] Group 1: H-share Issuance Details - The total number of H-shares for global offering is 104,225,400 shares, with 10,422,600 shares allocated for public offering in Hong Kong and 93,802,800 shares for international offering [1] - The estimated net proceeds from the global offering, based on an H-share price of HKD 34.00 per share, is approximately HKD 34.3261 billion [1]

Core Viewpoint - Zhongwei Co., Ltd. is set to list its H-shares on the Hong Kong Stock Exchange on November 17, marking a significant step in its growth within the new energy battery materials and metals sector [1][4]. Financial Performance - Total assets of Zhongwei Co., Ltd. increased from 2.029 billion RMB at the end of 2017 to 74.694 billion RMB by June 2025 [1]. - Operating revenue rose from 1.861 billion RMB in 2017 to an estimated 40.223 billion RMB in 2024 [1]. - The company's net profit, excluding non-recurring items, grew from 12 million RMB in 2017 to an estimated 1.281 billion RMB in 2024 [1]. Market Capitalization - As of the close on November 14, Zhongwei Co., Ltd.'s total market capitalization for its A-shares was 46.5 billion RMB [2]. H-Share Offering Details - The company plans to issue 104 million H-shares, with 10.4226 million shares available for public offering in Hong Kong and 93.8028 million shares for international offering [4]. - The estimated net proceeds from the global offering, assuming no exercise of the over-allotment option, is approximately 3.433 billion HKD, based on an offering price of 34 HKD per share [4].

Core Viewpoint - Zhongwei Co., Ltd. announced a global offering of H-shares, with a total of approximately 104 million shares to be issued before the exercise of the over-allotment option, aiming to raise an estimated net amount of approximately HKD 3.43261 billion [1] Summary by Sections - **Global Offering Details** - The total number of H-shares for the global offering is approximately 104 million shares, with 10.4226 million shares allocated for public offering in Hong Kong and 93.8028 million shares for international offering [1] - **Pricing and Proceeds** - The offering price for each H-share is set at HKD 34.00, and after deducting underwriting commissions and other estimated expenses, the net proceeds from the global offering are expected to be approximately HKD 3.43261 billion, assuming the over-allotment option is not exercised [1]